Financhill
Back

Galmed Pharmaceuticals Stock Predictions

Galmed Pharmaceuticals Stock Forecast

  • Is Galmed Pharmaceuticals Stock Undervalued?
    The current Galmed Pharmaceuticals [GLMD] share price is $0.39. The Score for GLMD is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • GLMD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Galmed Pharmaceuticals Stock Go Up Next Year?

Data Unavailable

Galmed Pharmaceuticals Stock Rating

Data Unavailable

Galmed Pharmaceuticals Stock Price History

Is GLMD stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GLMD is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Israel
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
galmedpharma.com

52-Week Data

52-Week High:
7.80
52-Week Low:
0.26

Prediction Charts

Market Cap:
2.33M
Price in USD:
0.39
Volume:
22.39K
Beta:
1.30

Technical Analysis

SMA50:
0.36
SMA100:
0.38
SMA200:
0.50
52-Wk Change:
-91.67%

Stock Predictions

  • Is Galmed Pharmaceuticals stock public?
    Yes, Galmed Pharmaceuticals is a publicly traded company.
  • What is the Galmed Pharmaceuticals stock quote today?
    The Galmed Pharmaceuticals stock price is 0.39 USD today.
  • How to buy Galmed Pharmaceuticals stock online?
    You can buy Galmed Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-16 0.37 0.35 0.37 0.33
Apr-17 0.35 0.37 0.38 0.34
Apr-18 0.37 0.38 0.38 0.36
Apr-19 0.38 0.37 0.38 0.37
Apr-22 0.37 0.36 0.37 0.35
Apr-23 0.36 0.36 0.36 0.35
Apr-24 0.38 0.40 0.40 0.36
Apr-25 0.37 0.39 0.39 0.36
Apr-26 0.39 0.39 0.39 0.37
Apr-29 0.39 0.38 0.40 0.37
Apr-30 0.38 0.37 0.40 0.35
May-1 0.35 0.39 0.39 0.34
May-2 0.39 0.39 0.40 0.38
May-3 0.40 0.39 0.40 0.37

Galmed Pharmaceuticals Earnings

Data Unavailable

Galmed Pharmaceuticals Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.70 per share, and an increase next year of $0.02 per share.

* Galmed Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.